These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37086829)

  • 21. Twenty-four-hour profiles of luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol levels: a semilongitudinal study throughout puberty in healthy boys.
    Albertsson-Wikland K; Rosberg S; Lannering B; Dunkel L; Selstam G; Norjavaara E
    J Clin Endocrinol Metab; 1997 Feb; 82(2):541-9. PubMed ID: 9024251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder.
    Wolraich ML; Greenhill LL; Pelham W; Swanson J; Wilens T; Palumbo D; Atkins M; McBurnett K; Bukstein O; August G
    Pediatrics; 2001 Oct; 108(4):883-92. PubMed ID: 11581440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventative treatment in an animal model of ADHD: Behavioral and biochemical effects of methylphenidate and its interactions with ovarian hormones in female rats.
    Lukkes JL; Freund N; Thompson BS; Meda S; Andersen SL
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1496-1506. PubMed ID: 27397110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.
    Somkuwar SS; Kantak KM; Dwoskin LP
    J Neurosci Methods; 2015 Aug; 252():55-63. PubMed ID: 25680322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation rearing as a preclinical model of attention/deficit-hyperactivity disorder.
    Yates JR; Darna M; Gipson CD; Dwoskin LP; Bardo MT
    Behav Brain Res; 2012 Oct; 234(2):292-8. PubMed ID: 22580232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pubertal administration of DEHP delays puberty, suppresses testosterone production, and inhibits reproductive tract development in male Sprague-Dawley and Long-Evans rats.
    Noriega NC; Howdeshell KL; Furr J; Lambright CR; Wilson VS; Gray LE
    Toxicol Sci; 2009 Sep; 111(1):163-78. PubMed ID: 19528224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in brain neurotrophic and glial factors following early age chronic methylphenidate and cocaine administration.
    Simchon-Tenenbaum Y; Weizman A; Rehavi M
    Behav Brain Res; 2015 Apr; 282():125-32. PubMed ID: 25576963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylphenidate and impulsivity: a comparison of effects of methylphenidate enantiomers on delay discounting in rats.
    Slezak JM; Ricaurte GA; Tallarida RJ; Katz JL
    Psychopharmacology (Berl); 2014 Jan; 231(1):191-8. PubMed ID: 23975034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric detection of Pig-A mutant red blood cells using an erythroid-specific antibody: application of the method for evaluating the in vivo genotoxicity of methylphenidate in adolescent rats.
    Dobrovolsky VN; Boctor SY; Twaddle NC; Doerge DR; Bishop ME; Manjanatha MG; Kimoto T; Miura D; Heflich RH; Ferguson SA
    Environ Mol Mutagen; 2010 Mar; 51(2):138-45. PubMed ID: 19658152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Quansah E; Ruiz-Rodado V; Grootveld M; Probert F; Zetterström TSC
    Neurochem Int; 2017 Sep; 108():109-120. PubMed ID: 28268188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats.
    Mohammed S; Sundaram V; Zyuzikov N
    J Ovarian Res; 2021 Feb; 14(1):26. PubMed ID: 33546719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term effects of adolescent methylphenidate exposure on brain striatal gene expression and sexual/endocrine parameters in male rats.
    Adriani W; Leo D; Guarino M; Natoli A; Di Consiglio E; De Angelis G; Traina E; Testai E; Perrone-Capano C; Laviola G
    Ann N Y Acad Sci; 2006 Aug; 1074():52-73. PubMed ID: 17105903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
    Soutullo C; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Bloomfield R; Squires LA; Coghill DR
    CNS Drugs; 2013 Sep; 27(9):743-51. PubMed ID: 23801529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylphenidate treatment increases hippocampal BDNF levels but does not improve memory deficits in hypoxic-ischemic rats.
    Miguel PM; Deniz BF; Confortim HD; de Almeida W; Bronauth LP; Vieira MC; Bertoldi K; Siqueira IR; Silveira PP; Pereira LO
    J Psychopharmacol; 2020 Jul; 34(7):750-758. PubMed ID: 32255391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testicular Function After Long-Term Methylphenidate Treatment in Boys with Attention-Deficit/Hyperactivity Disorder.
    Wang LJ; Lee SY; Chou WJ; Lee MJ; Tsai CS; Lee TL; Yang CJ; Yang KC; Chen CK; Shyu YC
    J Child Adolesc Psychopharmacol; 2019 Aug; 29(6):433-438. PubMed ID: 30575416
    [No Abstract]   [Full Text] [Related]  

  • 38. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
    Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
    Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder.
    Bouziane C; Filatova OG; Schrantee A; Caan MWA; Vos FM; Reneman L
    Radiology; 2019 Oct; 293(1):186-192. PubMed ID: 31407970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.